Online citations, reference lists, and bibliographies.
← Back to Search

Chitosan-Grafted Copolymers And Chitosan-Ligand Conjugates As Matrices For Pulmonary Drug Delivery

Fernanda Andrade, F. Goycoolea, D. Chiappetta, J. Neves, A. Sosnik, B. Sarmento
Published 2011 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Recently, much attention has been given to pulmonary drug delivery by means of nanosized systems to treat both local and systemic diseases. Among the different materials used for the production of nanocarriers, chitosan enjoys high popularity due to its inherent characteristics such as biocompatibility, biodegradability, and mucoadhesion, among others. Through the modification of chitosan chemical structure, either by the addition of new chemical groups or by the functionalization with ligands, it is possible to obtain derivatives with advantageous and specific characteristics for pulmonary administration. In this paper, we discuss the advantages of using chitosan for nanotechnology-based pulmonary delivery of drugs and summarize the most recent and promising modifications performed to the chitosan molecule in order to improve its characteristics.
This paper references
Novel self-aggregates of chitosan oligosaccharide grafted stearic acid: preparation, characterization and protein association.
F. Hu (2006)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
and C
Y. C. Huang (2005)
10.1155/2011/148763
Hydrodynamic Delivery of Chitosan-Folate-DNA Nanoparticles in Rats with Adjuvant-Induced Arthritis
Q. Shi (2011)
10.1016/J.IJPHARM.2006.10.021
Nanoparticles--a historical perspective.
J. Kreuter (2007)
10.1007/s11095-009-9894-2
Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery
Jean Sung (2009)
10.1080/10611860902737920
Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies
Y. Zheng (2009)
and Z
X. Wang (2009)
10.1016/j.colsurfb.2008.11.030
Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin.
Yong-Zhong Du (2009)
and W
E. I. Rabea (2003)
10.1002/JPS.2600790604
Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.
P. Artursson (1990)
10.1016/J.IJPHARM.2006.02.026
A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies.
F. Hu (2006)
10.1053/RMED.2002.1457
Fundamentals of pulmonary drug delivery.
D. Groneberg (2003)
10.1046/J.1365-2125.2003.01893.X
Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.
N. Labiris (2003)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.1021/BM015548S
Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH.
N. Fang (2001)
and D
C. Yan (2010)
and E
M. Silva (2001)
and M
N. Csaba (2009)
10.1136/bmj.323.7325.1375/a
I and i
K. Barraclough (2001)
and S
B. Sayin (2007)
10.1016/J.MICROMESO.2006.02.019
Synthesis and characterization of tungsten-substituted SBA-15: An enhanced catalyst for 1-butene metathesis
J. Hu (2006)
10.2217/17435889.3.1.1
From fluorescence nanoscopy to nanoscopic medicine.
R. Peters (2008)
10.1016/j.addr.2008.09.005
Nanoparticles for nasal vaccination.
N. Csaba (2009)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
and F
J. Liaw (2001)
and A
C. Chatelet (2001)
Antitumor e ff ect of N - succinyl - chitosan nanoparticles on K 562 cells
A. Dal Pozzo
10.1021/bm800835e
Carboxymethyl chitosan as a matrix material for platinum, gold, and silver nanoparticles.
Michael J. Laudenslager (2008)
10.1023/B:PHAM.0000012150.60180.e3
Effect of Chitosan on Epithelial Cell Tight Junctions
J. Smith (2004)
10.1016/S0939-6411(99)00039-9
Polymeric micelles - a new generation of colloidal drug carriers.
M. Jones (1999)
Gene delivery using chitosan
O. Germershaus (2008)
and L
C. Zhang (2006)
10.1016/J.JCONREL.2005.09.034
Block copolymer micelles: preparation, characterization and application in drug delivery.
G. Gaucher (2005)
10.1016/J.JCONREL.2005.01.001
Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency.
T. Kean (2005)
10.1515/9783111697888-004
B
B. A. R. Kernfach (1824)
10.1515/9783111548050-028
Q
Chlorpromazine Thorazine (1824)
10.4155/tde.13.89
Pulmonary drug delivery.
P. Kwok (2013)
10.1515/9783111419787-003
H
Yu-Qin Cao (1824)
and M
C. Yan (2006)
10.2174/138527210790231919
Chitosan Amphiphilic Derivatives. Chemistry and Applications
I. Aranaz (2010)
10.1016/J.PROGPOLYMSCI.2007.05.009
Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery
N. Rapoport (2007)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
and P
N.G.M. Schipper (1997)
10.1002/JBM.A.30421
Pulmonary inflammation caused by chitosan microparticles.
Y. Huang (2005)
10.1016/J.JCONREL.2005.11.014
Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
M. Amidi (2006)
and K
N. Fang (2001)
and R
A. Dal Pozzo (2000)
10.1021/bm800276d
Why is chitosan mucoadhesive?
Ioannis A Sogias (2008)
10.1016/j.ijpharm.2010.10.038
Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
Caixia Fan (2011)
10.1021/bm100384z
Nanoglycan complex formulation extends VEGF retention time in the lung.
E. H. Lauten (2010)
10.1016/j.toxlet.2010.08.016
Chitosan nanoparticles show rapid extrapulmonary tissue distribution and excretion with mild pulmonary inflammation to mice.
M. Choi (2010)
10.1046/J.1365-2125.2003.01892.X
Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.
N. Labiris (2003)
10.1016/j.biopha.2009.09.002
Antitumor effect of N-succinyl-chitosan nanoparticles on K562 cells.
Huiying Luo (2010)
10.1016/j.ddtec.2005.05.008
Chitosan and the mucosal delivery of biotechnology drugs.
Mohamed M. Issa (2005)
10.1021/mp100210g
Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
B. Slütter (2010)
10.1002/JBM.1270
Evaluation of the biocompatibility of a chitosan scaffold in mice.
P. VandeVord (2002)
10.1016/j.biomaterials.2010.06.005
The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections.
B. Bharatwaj (2010)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.5406/j.ctvpj7hjj.15
What are “ A ” and “ B ” ?
A. News
10.1515/9783050077338-026
Y
E. M. S. J. xviii (1824)
10.1016/j.colsurfb.2008.10.020
Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan.
Dong-hyuk Seo (2009)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin.
X. Wang (2009)
10.1002/APP.23040
Effect of degree of substitution and molecular weight of carboxymethyl chitosan nanoparticles on doxorubicin delivery
X. Shi (2006)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
and M
R. Fernandez-Urrusuno (1999)
Polysac - charide — based nanoparticles as carriers for drug and vaccine delivery
S. Farber (2007)
10.1016/j.biomaterials.2010.03.066
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
L. Fan (2010)
and R
Q. Yuan (2008)
10.3109/10611861003733987
Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel
S. Sahu (2011)
10.1081/DDC-120016724
N-Trimethyl Chitosan Chloride: Optimum Degree of Quaternization for Drug Absorption Enhancement Across Epithelial Cells
J. Hamman (2003)
10.1038/mt.2008.99
Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis.
J. Fernandes (2008)
10.1016/J.EJPB.2007.08.009
Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
X. Zhang (2008)
10.1016/S0378-5173(99)00030-7
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
and W
B. Slutter (2010)
10.1016/S0142-9612(00)00183-6
Influence of the degree of acetylation on some biological properties of chitosan films.
C. Châtelet (2001)
10.1016/j.ijpharm.2010.01.037
Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector.
V. B. Morris (2010)
Bone - protective e ff ects of nonviral gene therapy with folate - chitosan DNA nanoparticle containing interleukin - 1 receptor antagonist gene in rats with adjuvant - induced arthritis
Kadiyala (2008)
Block copolymer micelles: preparation
G. Gaucher (2005)
10.1016/s1773-2247(10)50007-8
Thiolated chitosans.
A. Bernkop-Schnürch (2004)
10.1002/jps.21464
Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
Yi-qing Ye (2009)
10.1021/CR030441B
Chitosan chemistry and pharmaceutical perspectives.
M. Kumar (2004)
and M
J. Smith (2004)
10.1248/YAKUSHI.126.789
Preparation of N-succinyl-chitosan and its physical-chemical properties as a novel excipient.
Chengyun Yan (2006)
10.1016/S0378-5173(98)00378-0
Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA.
S. Richardson (1999)
10.1016/J.COLSURFB.2006.11.031
Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives.
C. Zhang (2007)
10.1016/S0168-3659(99)00131-5
Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
M. Thanou (2000)
10.1016/j.ijbiomac.2010.11.005
Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells.
Yong-Zhong Du (2011)
10.1093/JAC/DKG477
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
R. Pandey (2003)
10.1016/S0939-6411(03)00061-4
Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins.
V. Leitner (2003)
10.1016/j.addr.2009.09.004
Biodegradation, biodistribution and toxicity of chitosan.
T. Kean (2010)
10.1002/jps.22274
Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.
K. Gilani (2011)
10.1136/BJO.46.11.704
A and V
R. Stephenson (1962)
and A
V. M. Leitner (2003)
and D
A. Bernkop-Schnürch (2004)
Chitosanpoly(ε-caprolactone)-poly(ethylene glycol) graft copolymers: synthesis
C. Chen (2011)
and H
A. B. Sieval (1998)
10.1016/S0939-6411(03)00147-4
Review articleThiolated chitosans
A. Bernkop-Schnürch (2004)
10.1515/9783111548050-035
Z
Axel M. Gressner (2012)
10.1016/S0168-3659(00)00298-4
Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier.
I. Park (2000)
10.1016/J.VACCINE.2006.11.034
Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
D. Zaharoff (2007)
and F
W. J. Lin (2011)
and C
J. Zhou (2010)
10.1016/S0378-5173(01)00914-0
Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia.
J. Hamman (2002)
10.1016/B978-0-12-405191-1.00012-0
Synthesis
P. Wakeley (2013)
10.1007/s11095-010-0255-y
Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles
E. J. B. Nielsen (2010)
and P
S. K. Sahu (2010)
10.1007/s10856-010-3998-4
In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery
S. Sahu (2010)
10.1023/A:1011092613951
Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs
M. Thanou (2004)
10.1016/j.carres.2011.01.027
Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells.
P. Li (2011)
and Y
H. Yamamoto (2005)
and D
J. C. Sung (2007)
Why is chitosan mucoadhesive?” Biomacromolecules
I. A. Sogias (2008)
and Y
J.M.A. Abdulla (2010)
10.1016/J.JCONREL.2005.04.015
Enhancement of carboplatin toxicity by Pluronic block copolymers.
A. Exner (2005)
10.1016/J.BIOMATERIALS.2005.09.020
Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
Sania Mansouri (2006)
10.1016/J.JCONREL.2006.12.007
Ethanol enhanced in vivo gene delivery with non-ionic polymeric micelles inhalation.
Yen-Chin Chao (2007)
10.2307/j.ctvrnfqk1.10
? ? ? ? f ? ? ? ? ?
A. ADoefaa (2003)
10.1007/s11095-006-0027-x
Chitosan-Modified Dry Powder Formulations for Pulmonary Gene Delivery
Hao-ying Li (2006)
10.2147/IJN.S1045
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
Malgorzata Smola (2008)
10.1002/mabi.200700190
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
M. de la Fuente (2008)
and L
P. Artursson (1994)
X
Y. Zheng (2009)
and K
I. Kadiyala (2010)
10.1016/J.TIBTECH.2007.09.005
Nanoparticles for drug delivery to the lungs.
Jean Sung (2007)
10.1211/jpp.58.8.0002
Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery
S. Chopra (2006)
10.1016/J.EJPS.2007.02.008
Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.
A. Grenha (2007)
10.1002/jbm.a.32965
Chitosan-poly(ε-caprolactone)-poly(ethylene glycol) graft copolymers: synthesis, self-assembly, and drug release behavior.
C. Chen (2011)
10.1016/j.ejps.2009.01.004
PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
Guowei Qu (2009)
and M
D. Teijeiro-Osorio (2009)
10.1016/J.BIOMATERIALS.2007.11.029
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
C. Zhang (2008)
10.1023/A:1012160102740
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
10.1016/S0169-409X(96)00401-2
Polymeric micelles as new drug carriers
G. Kwon (1996)
10.1039/c0nr00821d
Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging.
D. Bhattacharya (2011)
10.1016/S0169-409X(02)00019-4
PEG-based micelles as carriers of contrast agents for different imaging modalities.
V. Torchilin (2002)
A New vaccine delivery system with chitosan derivatives for intranasal immunization: in vitro/in vivo evaluations
B. Sayin (2007)
10.1016/j.vaccine.2009.04.033
Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
M. Bivas-Benita (2009)
Polysaccharide—based nanoparticles as carriers for drug and vaccine delivery
M. J. Alonso (2007)
and S
F. Q. Hu (2006)
and G
Y. Li (2011)
10.1016/J.COLSURFB.2006.04.009
Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel.
F. Hu (2006)
10.1016/J.IJPHARM.2006.11.027
Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Fu Chen (2007)
10.1016/J.JCONREL.2007.10.013
Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.
Oliver Germershaus (2008)
10.1166/JNN.2006.426
Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate.
Nazar Noureen Gaber (2006)
10.1023/A:1011981000671
Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability
P. Erbacher (2004)
10.1271/BBB.59.1901
Chitosan-derived polymer-surfactants and their micellar properties.
H. Yoshioka (1995)
10.1208/s12249-010-9428-6
Rehydrated Lyophilized Rifampicin-Loaded mPEG–DSPE Formulations for Nebulization
J. Abdulla (2010)
10.1016/j.ejpb.2007.10.017
Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
A. Grenha (2008)
10.1021/JF061541W
Novel chitosan-derived nanomaterials and their micelle-forming properties.
C. Zhang (2006)
and H
M. Thanou (2001)
10.1016/j.ijpharm.2010.07.001
Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.
Abdallah Makhlof (2010)
Biodegradation
T. Kean (2010)
and X
H. Luo (2010)
and H
F. Q. Hu (2008)
10.1515/9783111548050-034
W
Lohmarer Stadtgeschichte (2005)
10.1016/J.EJPB.2007.09.018
Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
F. Hu (2008)
and O
B. Sayin (2009)
Preparation and characterization of N - succinyl - N ’ - octyl chitosan micelles as doxorubicin carriers for e ff ective anti - tumor activity
Z. Jianping
and M
C. Prego (2006)
and M
K. A. Janes (2001)
10.1016/S0144-8617(03)00090-0
Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol
Can Zhang (2003)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1023/A:1018869601502
In Vitro Evaluation of Microparticles and Polymer Gels for Use as Nasal Platforms for Protein Delivery
C. Witschi (2004)
10.1016/J.COLSURFB.2006.12.006
Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
Xu Xiang-yang (2007)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
and A
J. H. Hamman (2002)
and H
A. Makhlof (2010)
and M
F. M. Goycoolea (2008)
10.1016/J.VIROL.2004.04.021
Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis.
Z. Zhu (2004)
10.1016/S0168-3659(02)00009-3
Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery.
A. Kabanov (2002)
and P
P. J. Vandevord (2002)
10.1016/S0960-894X(01)00285-2
Antioxidant activity of water-soluble chitosan derivatives.
W. Xie (2001)
10.1016/S0939-6411(99)00006-5
Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
A. Kotzé (1999)
10.1016/J.CARBPOL.2008.08.017
Water-soluble N-carboxymethylchitosan derivatives: Preparation, characteristics and its application
N. An (2009)
A. and Q
Neil Genzlinger (2006)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
and L
X. Shi (2006)
and H
Y. Wu (2009)
and C
X. Zhang (2008)
and G
B. I. Florea (2006)
and T
Y. T. Yang (2010)
10.1007/BF03218904
Methotrexate-incorporated polymeric micelles composed of methoxy poly(ethylene glycol)-grafted chitosan
Y. I. Jeong (2009)
10.1016/j.jconrel.2010.06.009
Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
B. Slütter (2010)
10.1016/S0169-409X(01)00180-6
Chitosan and its derivatives as intestinal absorption enhancers.
M. Thanou (2001)
10.1146/annurev.nu.16.070196.002441
Folate receptors.
A. Antony (1996)
10.1016/0378-5173(92)90353-4
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
C. Lehr (1992)
10.1517/17425247.2010.514604
Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery
Nicolas Duceppe (2010)
10.1002/ART.10405
Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.
M. Turk (2002)
10.1002/ARDP.200500039
Potential Tuberculostatic Agent: Micelle‐forming Pyrazinamide Prodrug
M. Silva (2006)
and W
M. Amidi (2006)
Chitosan amphiphilic derivatives
I. Aranaz (2010)
and A
M.N.V. Kumar (2004)
and H
C. M. Lehr (1992)
Novel selfaggregates of chitosan oligosaccharide grafted stearic acid: preparation
F. Q. Hu (2006)
and L
P. Li (2011)
and M
T. Kean (2005)
10.1023/A:1011901921995
Development of Novel Chitosan Derivatives as Micellar Carriers of Taxol
A. Miwa (2004)
10.1016/j.ejps.2009.08.010
TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
B. Sayin (2009)
10.1515/9783111438443-006
N
Città DI Torino (1824)
10.1515/9783486731620-002
I
John B. Shoven (1824)
10.1016/J.CARBPOL.2010.02.009
Synthesis and evaluation of N-succinyl-chitosan nanoparticles toward local hydroxycamptothecin delivery
Z. Hou (2010)
10.1023/A:1011054930439
Novel Polymeric Micelles Based on the Amphiphilic Diblock Copolymer Poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide)
A. Benahmed (2004)
10.1158/1535-7163.MCT-05-0540
Mannosylated chitosan nanoparticle–based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells
T. Kim (2006)
and S
B. Bharatwaj (2010)
10.1007/s10856-011-4302-y
Preparation and characterization of self-assemblied nanoparticles based on folic acid modified carboxymethyl chitosan
Yu-long Tan (2011)
10.1023/B:PHAM.0000048190.53439.eb
Block Copolymer Design for Camptothecin Incorporation into Polymeric Micelles for Passive Tumor Targeting
P. Opanasopit (2004)
10.1016/S1773-2247(06)50061-9
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
ect of degree of quaternization of N - trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco - 2 cell monolayers
A. F. Kotzé (2000)
10.1016/J.LFS.2006.09.040
Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Fang Zheng (2007)
and A
D. A. Groneberg (2003)
and A
H. M. Aliabadi (2005)
10.1515/9783111413426-016
Assessing L2 Writing in the Absence of Scoring Procedures: Construction of Rating Scales in a Cypriot-greek Efl in Class Context
Olivier Giraud (1824)
and F
C. Shruti (2006)
and C
T. H. Kim (2006)
10.1021/BM034130M
Chitosan as antimicrobial agent: applications and mode of action.
E. Rabea (2003)
10.1016/S0300-9084(86)80004-9
Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor.
A. Dautry-Varsat (1986)
10.1533/9781845694814.5.644
25 – Chitosan-polysaccharide blended nanoparticles for controlled drug delivery
J. M. Alonso (2008)
10.3109/10717544.2010.520355
In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel
J. Liu (2011)
and S
H. Yoshioka (1995)
10.1016/J.JCONREL.2005.02.015
Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
H. M. Aliabadi (2005)
10.1038/sj.gt.3301485
In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles
J. Liaw (2001)
10.1016/J.JCONREL.2004.10.010
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
H. Yamamoto (2005)
10.1016/j.jconrel.2005.10.001
Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation.
B. Florea (2006)
10.1208/s12249-009-9290-6
Development of Budesonide Microparticles Using Spray-Drying Technology for Pulmonary Administration: Design, Characterization, In Vitro Evaluation, and In Vivo Efficacy Study
Sonali R. Naikwade (2009)
10.1016/J.CARBPOL.2010.07.030
The preparation and characterization of a novel amphiphilic oleoyl-carboxymethyl chitosan self-assembled nanoparticles
Y. Li (2011)
10.1016/J.CARBPOL.2006.10.019
Synthesis, characterization and drug delivery behaviors of new PCP polymeric micelles
Der Zen Liu (2007)
10.1080/10611860400011935
Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids
Junping Wang (2005)
10.1016/S0144-8617(98)00009-5
Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride
A. Sieval (1998)
10.1208/s12248-009-9172-6
Spray-Dried Microparticles Containing Polymeric Micelles Encapsulating Hematoporphyrin
Yu-Tsai Yang (2009)
10.1016/j.nano.2010.05.005
Advances in polymeric micelles for drug delivery and tumor targeting.
U. Kedar (2010)
10.1007/S10965-008-9197-Z
Polymeric micelle composed of PLA and chitosan as a drug carrier
Yan Wu (2009)
10.1016/S0144-8617(99)00134-4
Preparation and characterization of poly(ethylene glycol)-crosslinked reacetylated chitosans
A. D. Pozzo (2000)
10.1016/J.JCONREL.2006.06.029
Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo.
Mohamed M. Issa (2006)
10.1016/j.actbio.2008.02.002
A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer.
Q. Yuan (2008)
and Y
N. N. Gaber (2006)
and A
M. Smola (2008)
10.1016/J.CARBPOL.2010.08.072
Synthesis of lactobionic acid-grafted-pegylated-chitosan with enhanced HepG2 cells transfection
W. Lin (2011)
Watersoluble N-carboxymethylchitosan derivatives: preparation
N. T. An (2009)
and T
P. Opanasopit (2004)
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
R. Lee (1994)
10.1021/bm800975j
New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
D. Teijeiro-Osorio (2009)
10.1007/s11095-006-9132-0
Micellar Nanocarriers: Pharmaceutical Perspectives
V. Torchilin (2006)
10.1002/1521-4184(200106)334:6<189::AID-ARDP189>3.0.CO;2-6
Potential Tuberculostatic Agents: Micelle‐Forming Copolymer Poly(ethylene glycol)‐Poly(aspartic acid) Prodrug with Isoniazid
M. Silva (2001)
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
10.1128/AAC.36.10.2310
Effects of the aggregation state of amphotericin B on its toxicity to mice.
J. Barwicz (1992)
10.1016/j.jcis.2010.02.004
Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and Folic acid binding to achieve selective cell targeting.
J. Zhou (2010)
10.1515/9783111548050-024
M
M. Sankar (1824)
and Y
M. Watanabe (2006)
and P
M. M. Issa (2005)
and M
M. J. Alonso (2007)
and K
Y. Bae (2005)
and F
Y. Z. Du (2009)
and H
K. Gilani (2011)
10.1016/j.biomaterials.2009.09.008
Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
F. Hu (2009)
10.1248/YAKUSHI.130.801
In vivo biodistribution for tumor targeting of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) nanoparticles.
Chengyun Yan (2010)
10.1016/J.CARBPOL.2010.08.008
Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells
A. Anitha (2011)
10.1016/J.CARBPOL.2009.10.050
Antioxidant activity of chitooligosaccharides upon two biological systems: Erythrocytes and bacteriophages
João Catalão (2010)
10.1039/B500266D
Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery.
Y. Bae (2005)
10.1016/j.colsurfb.2010.08.045
Synthesis, characterization and cytotoxicity studies of chitosan-coated tea polyphenols nanoparticles.
J. Liang (2011)
10.1016/j.ejps.2009.11.002
Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.
I. Kadiyala (2010)
10.1080/10717540903047387
Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles
Zhongbing Liu (2009)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1002/JPS.2600790710
Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells.
P. Artursson (1990)
10.1017/CBO9781139207249.009
I and J
William M. Marsden (2012)
Nanoparti - cles for nasal vaccination
S. Roth Kean
and Y
F. Chen (2007)
10.1016/J.IJPHARM.2005.10.030
Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
M. Watanabe (2006)
10.1086/586739
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
B. Rijnders (2008)
10.1016/j.ijpharm.2009.08.009
Receptor mediated gene delivery by folate conjugated N-trimethyl chitosan in vitro.
Y. Zheng (2009)
10.1021/bc9004798
Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells.
Shu-Jyuan Yang (2010)
10.1016/j.jconrel.2010.01.007
Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
B. Slütter (2010)
10.1163/092050610X512414
Anticancer Activity of Released Doxorubicin from a Folate-Mediated Polyelectrolyte Complex
Chien Chih Chiu (2011)
and L
C. C. Chiu (2011)



This paper is referenced by
Development of chitosan-grafted polycaprolactone copolymer for mucoadhesive nanodelivery systems
A. Almeida (2016)
Spray-dried bioadhesive formulations for pulmonary delivery
H. Omer (2014)
10.1007/978-981-13-8063-1_8
Bionanopolymers for drug delivery
V. Fasiku (2019)
10.1166/JBN.2014.1887
Production of drug-loaded polymeric nanoparticles by electrospraying technology.
A. Sosnik (2014)
10.1016/j.carbpol.2019.115734
A new waterborne chitosan-based polyurethane hydrogel as a vehicle to transplant bone marrow mesenchymal cells improved wound healing of ulcers in a diabetic rat model.
Christian Viezzer (2020)
10.3390/ijms131113966
Novel High-Viscosity Polyacrylamidated Chitosan for Neural Tissue Engineering: Fabrication of Anisotropic Neurodurable Scaffold via Molecular Disposition of Persulfate-Mediated Polymer Slicing and Complexation
P. Kumar (2012)
10.1142/9789814520652_0022
Nanopreparations for Oral Administration
D. Hubbard (2014)
10.1016/j.addr.2013.09.002
Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing "Generally Recognized As Safe" (GRAS) nanopharmaceuticals: A review.
A. Sosnik (2013)
Development of fucoidan/chitosan nanoparticulate systems for protein administration through mucosal routes
Sara Ataíde Ferreira (2012)
10.1007/978-3-642-40123-7
Multifaceted Development and Application of Biopolymers for Biology, Biomedicine and Nanotechnology
P. Dutta (2013)
10.1016/J.JMMM.2016.07.066
Magnetic responsive of paclitaxel delivery system based on SPION and palmitoyl chitosan
Mona Mansouri (2017)
10.1080/17425247.2016.1178232
Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases
P. Rajitha (2016)
Neuroprotection by Chitosan and Chitosan Nanoparticles
Bojun Chen (2013)
10.2217/nnm.13.167
Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
Lesego L. Tshweu (2014)
10.1007/978-981-13-8855-2_15
Clinical Application of Biomimetic Marine-Derived Materials for Tissue Engineering
V. Lalzawmliana (2019)
10.3390/md14020034
Marine Origin Polysaccharides in Drug Delivery Systems
M. J. Cardoso (2016)
10.1016/j.ijbiomac.2015.10.041
Synthesis of raloxifene-chitosan conjugate: A novel chitosan derivative as a potential targeting vehicle.
F. Samadi (2016)
10.1016/J.PROGPOLYMSCI.2014.07.010
Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
A. Sosnik (2014)
10.1016/j.biotechadv.2015.01.003
Polymeric micelles in mucosal drug delivery: Challenges towards clinical translation.
A. Sosnik (2015)
10.1049/iet-nbt.2016.0055
Synthesis and characterisation of PEG modified chitosan nanocapsules loaded with thymoquinone.
S. V. Vignesh Kumar (2017)
10.1016/j.biomaterials.2014.10.026
Novel protease inhibitor-loaded Nanoparticle-in-Microparticle Delivery System leads to a dramatic improvement of the oral pharmacokinetics in dogs.
Julieta C. Imperiale (2015)
10.1002/9781118774052.CH5
Chitosan as an Advanced Healthcare Material
Jardine (2014)
10.1201/B15636-24
Chitosan and Chitosan Derivatives for Mucosal Delivery of Biopharmaceutical Drugs
Fernanda Andrade (2013)
10.2217/nnm-2016-0045
Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery.
Fernanda Andrade (2016)
10.1016/j.ijbiomac.2013.04.073
Chitosan/alginate crosslinked hydrogels: preparation, characterization and application for cell growth purposes.
K. Baysal (2013)
10.1016/j.carbpol.2012.08.009
Trimethyl and carboxymethyl chitosan carriers for bio-active polymer-inorganic nanocomposites.
Georg Geisberger (2013)
10.1039/c8dt02419g
Towards the development of chitosan nanoparticles for plutonium pulmonary decorporation.
Laurane Léost (2018)
10.24377/LJMU.T.00004499
PULMONARY DELIVERY OF PNEUMOCCOCAL VACCINE USING NANOCOMPOSITE MICROPARTICLE CARRIERS VIA DRY POWDER INHALATION
Iman M. Alfagih (2015)
10.1021/acs.molpharmaceut.5b00642
Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells.
A. Nascimento (2015)
10.1007/978-3-319-03751-6_45-1
Isolation, Purification, and Nanotechnological Applications of
J. Dutta (2014)
10.1007/978-3-030-46923-8
Advanced Biopolymeric Systems for Drug Delivery
A. Nayak (2020)
10.1016/J.COLSURFA.2017.10.067
Compressed hybrid cotton aerogels for stopping liquid leakage
H. Duong (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar